Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0311 Transporter Info | ||||
Gene Name | SLC35F6 | ||||
Transporter Name | ANT2-binding protein | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Valproic Acid affects the expression of SLC35F6 mRNA | [4] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation1 |
NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
2-bromopalmitate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
2-bromopalmitate inhibits the reaction Cadmium Chloride results in increased abundance of Cadmium which results in increased palmitoylation of SLC35F6 protein | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of SLC35F6 mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
abrine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
abrine results in increased expression of SLC35F6 protein | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
beta-lapachone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
beta-lapachone results in decreased expression of SLC35F6 mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol A affects the expression of SLC35F6 mRNA | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
bisphenol A results in decreased expression of SLC35F6 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
bisphenol A results in increased expression of SLC35F6 mRNA | [23] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol AF |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol AF results in increased expression of SLC35F6 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol B results in increased expression of SLC35F6 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol F results in increased expression of SLC35F6 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol S |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
bisphenol S results in increased expression of SLC35F6 protein | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
2-bromopalmitate inhibits the reaction Cadmium Chloride results in increased abundance of Cadmium which results in increased palmitoylation of SLC35F6 protein | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased palmitoylation of SLC35F6 protein | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
dicrotophos results in increased expression of SLC35F6 mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
di-n-butylphosphoric acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
di-n-butylphosphoric acid affects the expression of SLC35F6 mRNA | [25] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dorsomorphin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SLC35F6 mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
FR900359 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
FR900359 results in increased phosphorylation of SLC35F6 protein | [26] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Lactic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Lactic Acid results in decreased expression of SLC35F6 mRNA | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Rotenone |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Rotenone results in increased expression of SLC35F6 protein | [28] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite promotes the reaction SLC35F6 protein binds to CAPRIN1 protein | [29] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased expression of SLC35F6 mRNA | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Tetrachlorodibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tetrachlorodibenzodioxin results in increased expression of SLC35F6 mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Thiram |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Thiram results in decreased expression of SLC35F6 mRNA | [30] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
tris(2-butoxyethyl) phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(2-butoxyethyl) phosphate affects the expression of SLC35F6 mRNA | [31] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carcinogen |
|||||
Cadmium |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
2-bromopalmitate inhibits the reaction Cadmium Chloride results in increased abundance of Cadmium which results in increased palmitoylation of SLC35F6 protein | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Cadmium Chloride results in increased abundance of Cadmium which results in increased palmitoylation of SLC35F6 protein | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Nanoparticle |
|||||
perfluoro-n-nonanoic acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
perfluoro-n-nonanoic acid results in increased expression of SLC35F6 mRNA | [27] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Copper Sulfate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Copper Sulfate increases the expression of SLC35F6 | [1] | |||
Cyclosporine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cyclosporine increases the expression of SLC35F6 | [2] | |||
Acetaminophen |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Acetaminophen inhibits the expression of SLC35F6 | [3] | |||
DT Modulation2 |
Acetaminophen results in increased expression of SLC35F6 mRNA | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carbamazepine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Carbamazepine affects the expression of SLC35F6 | [4] | |||
Sunitinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sunitinib increases the expression of SLC35F6 | [5] | |||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol increases the expression of SLC35F6 | [6] | |||
Valproic Acid |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid increases the expression of SLC35F6 | [7] | |||
Drug in Phase 2 Trial |
|||||
Bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol A inhibits the expression of SLC35F6 | [15] | |||
Bisphenol B |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol B increases the expression of SLC35F6 | [15] | |||
Investigative Drug |
|||||
Phenylmercuric Acetate |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Phenylmercuric Acetate increases the expression of SLC35F6 | [11] | |||
Milchsaure |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Milchsaure inhibits the expression of SLC35F6 | [13] | |||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution increases the expression of SLC35F6 | [14] | |||
Caffeine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Caffeine results in increased phosphorylation of SLC35F6 protein | [24] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Environmental toxicant |
|||||
Polychlorinated dibenzodioxin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Polychlorinated dibenzodioxin increases the expression of SLC35F6 | [8] | |||
Bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Bisphenol F increases the expression of SLC35F6 | [15] | |||
Pesticide/Insecticide |
|||||
Dicrotophos |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Dicrotophos increases the expression of SLC35F6 | [12] | |||
Health and Environmental Toxicant |
|||||
tris(1,3-dichloro-2-propyl)phosphate |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
tris(1,3-dichloro-2-propyl)phosphate increases the expression of SLC35F6 | [10] | |||
Herbicide |
|||||
Atrazine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Atrazine inhibits the expression of SLC35F6 | [9] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.